.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Fish and Richardson
Colorcon
Dow
Moodys
McKinsey
Julphar
QuintilesIMS
Citi

Generated: July 25, 2017

DrugPatentWatch Database Preview

Acetazolamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acetazolamide and what is the scope of acetazolamide freedom to operate?

Acetazolamide
is the generic ingredient in three branded drugs marketed by Zydus Pharms Usa Inc, Alra, Heritage Pharma, Novast Labs Ltd, Lannett, Teva Branded Pharm, Mutual Pharm, Sun Pharm Inds, Vangard, Heritage Pharms Inc, Watson Labs, Ascot, Nostrum Labs Inc, Taro, Hospira, Par Sterile Products, Sagent Agila, X Gen Pharms, Teva Womens, West-ward Pharms Int, and Emcure Pharms Ltd, and is included in twenty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for acetazolamide. Eighteen suppliers are listed for this compound.

Summary for Generic Name: acetazolamide

Tradenames:3
Patents:1
Applicants:21
NDAs:23
Drug Master File Entries: see list10
Suppliers / Packagers: see list18
Bulk Api Vendors: see list63
Clinical Trials: see list80
Patent Applications: see list6,729
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:acetazolamide at DailyMed

Pharmacology for Ingredient: acetazolamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL040195-002May 28, 1997ABRXNoYes► Subscribe► Subscribe► Subscribe
Alra
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL083320-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ascot
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL087686-001Oct 20, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
X Gen Pharms
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION040784-001Dec 10, 2008APRXNoYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION040089-001Feb 28, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Accenture
Cerilliant
Deloitte
Novartis
Farmers Insurance
Boehringer Ingelheim
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot